Search

Coloplast A-S (Class B)

Închisă

569.8 -0.9

Rezumat

Modificarea prețului

24h

Curent

Minim

564.4

Maxim

579.4

Indicatori cheie

By Trading Economics

Venit

70M

875M

Vânzări

2M

7B

P/E

Medie Sector

35.807

90.831

EPS

3.88

Randament dividend

4.01

Marjă de profit

12.572

Angajați

16,744

EBITDA

2B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.01%

2.20%

Următoarele câștiguri

6 feb. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

7.5B

130B

Deschiderea anterioară

570.7

Închiderea anterioară

569.8

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

13 ian. 2026, 19:05 UTC

Principalele dinamici ale pieței

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 ian. 2026, 23:41 UTC

Market Talk

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 ian. 2026, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

13 ian. 2026, 23:33 UTC

Market Talk

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 ian. 2026, 23:13 UTC

Achiziții, Fuziuni, Preluări

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 ian. 2026, 23:10 UTC

Achiziții, Fuziuni, Preluări

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 ian. 2026, 23:03 UTC

Market Talk

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 ian. 2026, 21:50 UTC

Achiziții, Fuziuni, Preluări

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 ian. 2026, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 ian. 2026, 21:20 UTC

Achiziții, Fuziuni, Preluări

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 ian. 2026, 21:15 UTC

Achiziții, Fuziuni, Preluări

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 ian. 2026, 21:08 UTC

Achiziții, Fuziuni, Preluări

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 ian. 2026, 20:39 UTC

Market Talk

Silver Settles at Another New High -- Market Talk

13 ian. 2026, 20:21 UTC

Market Talk

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 ian. 2026, 20:17 UTC

Market Talk

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 ian. 2026, 19:08 UTC

Achiziții, Fuziuni, Preluări

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 ian. 2026, 19:03 UTC

Câștiguri

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 ian. 2026, 18:50 UTC

Câștiguri

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 ian. 2026, 17:54 UTC

Market Talk

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 ian. 2026, 17:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Global Equities Roundup: Market Talk

13 ian. 2026, 17:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 ian. 2026, 17:49 UTC

Market Talk

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 ian. 2026, 17:38 UTC

Market Talk

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 ian. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

13 ian. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 ian. 2026, 17:20 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Basic Materials Roundup: Market Talk

13 ian. 2026, 17:19 UTC

Market Talk

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 ian. 2026, 17:15 UTC

Market Talk

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat